when rimonabant will be approved

June 2008

People are asking when rimonabant will be approved.

Not for a few years...and possibly never.

Rimonabant (Acomplia, Zimulti) has been in the news as a promising drug for obesity, smoking cessation, dyslipidemia, and diabetes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote